US: end of teen nicotine vaping epidemic and eradication of tobacco smoking

The use of e-cigarette among teenagers in the United States is considered a significant public health problem. A close look at federal data now show that the number of young e-cigarette users has markedly declined to below epidemic levels since its peak in 2019.

Continue ReadingUS: end of teen nicotine vaping epidemic and eradication of tobacco smoking

First study in the world to evaluate efficacy and safety of the antismoking drug varenicline for smokers with Diabetes

A recent randomized controlled trial of varenicline (Chantix) combined with psychological support has significantly increased the chance of quitting smoking for 300 smokers with type 2 diabetes mellitus

Continue ReadingFirst study in the world to evaluate efficacy and safety of the antismoking drug varenicline for smokers with Diabetes

The first review to assess the metabolic impact of stopping smoking in patients with diabetes mellitus revealed serious gaps in the literature

Quitting smoking can reduce cardiovascular and kidney failure risks. However, it can lead to side effects such as weight gain. A scoping review conducted by a pool of European researchers revealed a lack of data on the metabolic effects of smoking and smoking cessation in diabetes. Healthcare professionals should not assume that cessation of smoking will improve metabolic parameters in patients with diabetes.

Continue ReadingThe first review to assess the metabolic impact of stopping smoking in patients with diabetes mellitus revealed serious gaps in the literature

No Tobacco Day, 31 May 2022: smoker number increased, concrete answers needed 

Yesterday, the Italian Ministry of Health released new data on smoking prevalence: there are 800000 more smokers in the country than in 2019. Rates increased especially among women and young people. The report found that also the numbers of the users of heated tobacco products and electronic cigarettes is rising. “An expected disaster, partly anticipated by our data published in 2020 and obtained thanks to a study conducted during the acute phase of Covid-19 pandemic. Since then, no prevention policies, no answers from the Italian health authorities. Reporting a disaster is not enough: we need to come up with alternative and effective solutions”. Stated professor Riccardo Polosa, founder of the CoEHAR, who opened the first National Conference on Tobacco Harm Reduction.

Continue ReadingNo Tobacco Day, 31 May 2022: smoker number increased, concrete answers needed 

Catania, world capital of antismoking research: the CoEHAR mural

As a tangible demonstration of the gratitude towards the city that marked the beginning of the change, this morning CoEHAR presented the “CoEHAR Mural” along A.Doria Avenue (near INFN- Institute of Nuclear Physics). The mural is an artistic work created by the collective “MaleTinte”, thanks to the patronage of the Municipality of Catania and the Italian Anti-smoking League, LIAF, and the support of the BCC, Cooperative Credit Bank of Regalbuto and PPG Italy Group.

Continue ReadingCatania, world capital of antismoking research: the CoEHAR mural
Read more about the article Experimental Biology 2022: CoEHAR flies to Philadelphia to present the Replica project
alfio distefano experimental biology

Experimental Biology 2022: CoEHAR flies to Philadelphia to present the Replica project

CoEHAR presented the results of the Replica project during Experimental Biology 2022, the annual meeting that brings together thousands of scientists and experts in the field of anatomy, biochemistry and molecular biology, investigative pathology, pharmacology, and physiology. Representing CoEHAR, the researcher Alfio Distefano, PhD student in neuroscience at the University of Catania

Continue ReadingExperimental Biology 2022: CoEHAR flies to Philadelphia to present the Replica project

CoEHAR exposes for the first time that most e-cigarette research is flawed and in need of urgent critical reform 

Under the leadership of CoEHAR, a team of international researchers, examined the 24 most frequently cited vaping studies published in medical journals. The findings are shocking: almost all of these studies were found to be methodologically flawed; they lacked a clear hypothesis, used inadequate methodology, failed to collect data relevant to the study objectives, and did not correct for obvious confounding factors. 

Continue ReadingCoEHAR exposes for the first time that most e-cigarette research is flawed and in need of urgent critical reform